Search Press releases Keywords From To 5 Aug 2020 CIMZIA[®] is the First and Only Biologic Approved in Europe with the Option for a Reduced Maintenance Dose for Patients Across the Full Axial Spondyloarthritis Spectrum Read More 30 Jul 2020 Acquisitions and disposals of own shares Read More 30 Jul 2020 Transparency notification FMR LLC. Read More 29 Jul 2020 UCB enters into collaboration with Roche to develop antibody treatment for people living with Alzheimer’s Disease Read More 27 Jul 2020 UCB Half Year Report 2020: UCB’s resilient product portfolio drives continued company growth Read More 24 Jul 2020 Disposals of own shares Read More Pagination First page Previous page Previous … Page 54 Page 55 Page 56 Page 57 Current page 58 Page 59 Page 60 Page 61 Page 62 … Page 58 of 66 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
